This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Texas Students Win Regional Siemens Competition At The University Of Texas At Austin For Research On Cancer Therapy And Vaccine Development

"It's top-tier science. Frederick discovered what could be a very promising new approach to treating cancer by making human cells transgenic," said competition judges Dr. Janice Fischer, professor, and Dr. Blerta Xhemalce, assistant professor, both in Molecular Biosciences, The University of Texas at Austin. "He commands a breadth of knowledge in technique and tools that is impressive for a high school student. The sophistication of the approach and the science of his research could serve as a cornerstone publication in the field."

Inspired by his parents' work as physicians in a cancer center, Frederick similarly is keen to pursue a profession in biomedical research, or as an engineer allowing him to apply both math and science. He is a National Merit Scholar Semifinalist, and a member of the Junior States of America club. Additionally, he is captain of his school's varsity soccer team and a two-year participant and "lead teacher" in the school's annual community service trip to Costa Rica.

His mentor is Dr. Anwar Hossain, senior research scientist, MD Anderson Cancer Center, Department of Neurosurgery.

The Winning Team

Alyssa Chen, a junior at Highland Park High School in Dallas, Texas, and Shriya Das, a junior at The Hockaday School in Dallas, Texas, won the team category and will share a $6,000 scholarship for their project entitled, Encapsulation of c-di-GMP Adjuvant into pH-tunable Micelle-based Nanoparticle Heightens Immune Response.

In their research on vaccine development, Alyssa and Shriya merged the disciplines of nanotechnology and immunology to develop adjuvants, molecules that can boost immune responses.  By encapsulating the adjuvant, the team was able to increase its potency and facilitate its delivery directly into the immune cell. The team's discovery could have the potential to develop more vaccines for cancer and difficult-to-cure infectious diseases.

2 of 5

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs